Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 23706974)

1.

Clinical significance of homocysteine (hcy) on dementia in Parkinson's disease (PD).

Song IU, Kim JS, Park IS, Kim YD, Cho HJ, Chung SW, Lee KS.

Arch Gerontol Geriatr. 2013 Nov-Dec;57(3):288-91. doi: 10.1016/j.archger.2013.04.015. Epub 2013 May 23.

PMID:
23706974
2.

Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia.

Zoccolella S, dell'Aquila C, Abruzzese G, Antonini A, Bonuccelli U, Canesi M, Cristina S, Marchese R, Pacchetti C, Zagaglia R, Logroscino G, Defazio G, Lamberti P, Livrea P.

Mov Disord. 2009 May 15;24(7):1028-33. doi: 10.1002/mds.22511.

PMID:
19353704
3.

Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients.

Camicioli RM, Bouchard TP, Somerville MJ.

Mov Disord. 2009 Jan 30;24(2):176-82. doi: 10.1002/mds.22227.

PMID:
18951534
4.

Plasma homocysteine levels and Parkinson disease: disease progression, carotid intima-media thickness and neuropsychiatric complications.

Hassin-Baer S, Cohen O, Vakil E, Sela BA, Nitsan Z, Schwartz R, Chapman J, Tanne D.

Clin Neuropharmacol. 2006 Nov-Dec;29(6):305-11.

PMID:
17095893
5.

Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital.

Ojo OO, Oladipo OO, Ojini FI, Sanya EO, Danesi MA, Okubadejo NU.

West Afr J Med. 2011 Sep-Oct;30(5):319-24.

PMID:
22752818
6.

Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients.

Lamberti P, Zoccolella S, Iliceto G, Armenise E, Fraddosio A, de Mari M, Livrea P.

Mov Disord. 2005 Jan;20(1):69-72.

PMID:
15390046
7.

Serum homocysteine and physical exercise in patients with Parkinson's disease.

Nascimento CM, Stella F, Garlipp CR, Santos RF, Gobbi S, Gobbi LT.

Psychogeriatrics. 2011 Jun;11(2):105-12. doi: 10.1111/j.1479-8301.2011.00356.x.

PMID:
21707858
8.

Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions.

Zoccolella S, Lamberti P, Iliceto G, Diroma C, Armenise E, Defazio G, Lamberti SV, Fraddosio A, de Mari M, Livrea P.

Clin Chem Lab Med. 2005;43(10):1107-10.

PMID:
16197306
9.

Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.

Białecka M, Kurzawski M, Roszmann A, Robowski P, Sitek EJ, Honczarenko K, Gorzkowska A, Budrewicz S, Mak M, Jarosz M, Gołąb-Janowska M, Koziorowska-Gawron E, Droździk M, Sławek J.

Pharmacogenet Genomics. 2012 Oct;22(10):716-24. doi: 10.1097/FPC.0b013e32835693f7.

PMID:
22890010
10.

Association of homocysteine with ventricular dilatation and brain atrophy in Parkinson's disease.

Sapkota S, Gee M, Sabino J, Emery D, Camicioli R.

Mov Disord. 2014 Mar;29(3):368-74. doi: 10.1002/mds.25798. Epub 2014 Jan 6.

PMID:
24395213
11.

Methylenetetrahydrofolate reductase polymorphisms and plasma homocysteine in levodopa-treated and non-treated Parkinson's disease patients.

Yuan RY, Sheu JJ, Yu JM, Hu CJ, Tseng IJ, Ho CS, Yeh CY, Hung YL, Chiang TR.

J Neurol Sci. 2009 Dec 15;287(1-2):64-8. doi: 10.1016/j.jns.2009.09.007. Epub 2009 Sep 27.

PMID:
19786283
12.

Elevated homocysteine levels in levodopa-treated idiopathic Parkinson's disease: a meta-analysis.

Hu XW, Qin SM, Li D, Hu LF, Liu CF.

Acta Neurol Scand. 2013 Aug;128(2):73-82. doi: 10.1111/ane.12106. Epub 2013 Feb 21. Review.

PMID:
23432663
13.

Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study.

Rodriguez-Oroz MC, Lage PM, Sanchez-Mut J, Lamet I, Pagonabarraga J, Toledo JB, García-Garcia D, Clavero P, Samaranch L, Irurzun C, Matsubara JM, Irigoien J, Bescos E, Kulisevsky J, Pérez-Tur J, Obeso JA.

Mov Disord. 2009 Jul 30;24(10):1437-44. doi: 10.1002/mds.22522.

PMID:
19452554
14.

Role of lifestyle factors on plasma homocysteine levels in Parkison's disease patients treated with levodopa.

Siniscalchi A, Gallelli L, Mercuri NB, Ibbadu GF, De Sarro G.

Nutr Neurosci. 2006 Feb-Apr;9(1-2):11-6. Review.

PMID:
16910165
15.

The impact of MRI white matter hyperintensities on dementia in Parkinson's disease in relation to the homocysteine level and other vascular risk factors.

Sławek J, Roszmann A, Robowski P, Dubaniewicz M, Sitek EJ, Honczarenko K, Gorzkowska A, Budrewicz S, Mak M, Gołąb-Janowska M, Koziorowska-Gawron E, Droździk M, Kurzawski M, Bandurski T, Białecka M.

Neurodegener Dis. 2013;12(1):1-12. doi: 10.1159/000338610. Epub 2012 Jul 20.

PMID:
22831964
16.

Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia?

Zoccolella S, Lamberti SV, Iliceto G, Santamato A, Lamberti P, Logroscino G.

Curr Med Chem. 2010;17(28):3253-61. Review.

PMID:
20666719
17.

Use of memantine (akatinol) for the correction of cognitive impairments in Parkinson's disease complicated by dementia.

Litvinenko IV, Odinak MM, Mogil'naya VI, Perstnev SV.

Neurosci Behav Physiol. 2010 Feb;40(2):149-55. doi: 10.1007/s11055-009-9244-1.

PMID:
20033305
18.

Hyperhomocysteinemia in L-dopa treated Parkinson's disease patients: effect of cobalamin and folate administration.

Lamberti P, Zoccolella S, Armenise E, Lamberti SV, Fraddosio A, de Mari M, Iliceto G, Livrea P.

Eur J Neurol. 2005 May;12(5):365-8.

PMID:
15804266
19.

Elevated plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with dyskinesias.

Zoccolella S, Lamberti P, Iliceto G, Dell'Aquila C, Diroma C, Fraddosio A, Lamberti SV, Armenise E, Defazio G, de Mari M, Livrea P.

Clin Chem Lab Med. 2006;44(7):863-6.

PMID:
16776634
20.

Coenzyme Q10, hyperhomocysteinemia and MTHFR C677T polymorphism in levodopa-treated Parkinson's disease patients.

Gorgone G, Currò M, Ferlazzo N, Parisi G, Parnetti L, Belcastro V, Tambasco N, Rossi A, Pisani F, Calabresi P, Ientile R, Caccamo D.

Neuromolecular Med. 2012 Mar;14(1):84-90. doi: 10.1007/s12017-012-8174-1. Epub 2012 Feb 22.

PMID:
22354693
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk